Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News HTG Molecular Diagnostics Inc HTGMQ

Healthcare Medical Devices
HTG Molecular Diagnostics, Inc. is a life science company. The Company is focused on advancing precision medicine and drug discovery through its transcriptome-wide profiling and advanced drug discovery platform technologies. The Company is engaged in the sales of its HTG EdgeSeq system and integrated next-generation sequencing-based (NGS-based) HTG EdgeSeq research use only (RUO) assays and... see more

Recent & Breaking News (GREY:HTGMQ)

HTG Molecular Diagnostics to Announce Q1 2021 Financial Results and Host Conference Call on Thursday, May 13

GlobeNewswire May 4, 2021

HTG Molecular Diagnostics Reports Preliminary First Quarter 2021 Financial Results

GlobeNewswire April 5, 2021

HTG Molecular Diagnostics Reports Full Year 2020 Results

GlobeNewswire March 25, 2021

HTG Molecular Diagnostics to Announce Year End 2020 Financial Results and Host Conference Call on Thursday, March 25

GlobeNewswire March 16, 2021

HTG Concludes Feasibility Testing & Releases Second White Paper for its Planned Whole Transcriptome Panel Using HTG EdgeSeq Technology

GlobeNewswire February 26, 2021

HTG Announces Board of Directors Transition

GlobeNewswire January 19, 2021

HTG Molecular Diagnostics Announces Certain Preliminary 2020 Unaudited Financial Results

GlobeNewswire January 5, 2021

HTG Expands Patent Portfolio with New Canadian Patent for its Nuclease Protection Methods for Detection of Nucleotide Variants

GlobeNewswire December 30, 2020

HTG Announces First Collaborator in Early Access Program for its Prototype Whole Transcriptome Panel

GlobeNewswire December 18, 2020

HTG Announces an Early Access Program for its Prototype Whole Transcriptome Panel

GlobeNewswire December 8, 2020

HTG Announces One-for-Fifteen Reverse Stock Split

GlobeNewswire November 23, 2020

HTG Molecular Diagnostics Reports Third Quarter 2020 Results

GlobeNewswire November 10, 2020

HTG Demonstrates Technical Feasibility for a Whole Transcriptome Panel Using HTG EdgeSeq Technology

GlobeNewswire November 2, 2020

HTG Molecular Diagnostics to Announce Third Quarter 2020 Financial Results and Host Conference Call on Tuesday, November 10

GlobeNewswire October 30, 2020

HTG Molecular Diagnostics to Present Corporate Overview at Fall Investor Conferences

GlobeNewswire September 8, 2020

HTG Introduces Oncology Applications and Expands Analytics Capabilities with Release of New Software Update

GlobeNewswire August 18, 2020

HTG Molecular Provides Update on Patent Infringement Claims Against BioSpyder

GlobeNewswire August 14, 2020

HTG Molecular Diagnostics Reports Second Quarter 2020 Results

GlobeNewswire August 11, 2020

HTG Molecular Diagnostics Announces New Commercialization and Distribution Agreement for Companion Diagnostics with QIAGEN

GlobeNewswire August 10, 2020

HTG Molecular Diagnostics to Announce Second Quarter 2020 Financial Results and Host Conference Call on Tuesday, August 11

GlobeNewswire August 5, 2020